<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2023-8-82-85</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-3125</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Коморбидная пищевая аллергия  у пациентов с врожденным буллезным эпидермолизом</article-title><trans-title-group xml:lang="en"><trans-title>Comorbid food allergy in patients  with congenital epidermolysis bullosa</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6701-3872</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галимова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Galimova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галимова Альбина Альбертовна, м. н. с. отдела профилактической педиатрии, врач аллерголог-иммунолог отделения стационарозамещающих технологий</p><p>Москва</p></bio><bio xml:lang="en"><p>Galimova Albina A., junior researcher at Dept of Preventive Pediatrics. MD of the Department of inpatient replacement technologies</p><p>Moscow</p></bio><email xlink:type="simple">albina86@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3056-403X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макарова</surname><given-names>С. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Makarova</surname><given-names>S. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Макарова Светлана Геннадиевна, д. м. н., зам. директора, руководитель центра профилактической педиатрии; проф. кафедры многопрофильной клинической подготовки факультета фундаментальной медицины</p><p> </p></bio><bio xml:lang="en"><p>Makarova Svetlana G., DM Sci, head of Center for Preventive Pediatrics; professor at Dept of Multidisciplinary Clinical Training, Faculty of Fundamental Medicine</p><p>Moscow</p></bio><email xlink:type="simple">sm27@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2252-8570</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мурашкин</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Murashkin</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мурашкин Николай Николаевич, д. м. н., проф., руководитель НИИ детской дерматологии; проф. кафедры дерматовенерологии и косметологии; проф. кафедры педиатрии и детской ревматологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Murashkin Nikolai N., DM Sci, professor, dermatovenerologist, head of Centre for Pediatric Dermatology, head of Dept of Dermatology with a Laser Surgery Group, head of Laboratory of Skin Pathology; professor of the Department of Pediatrics and Pediatric Rheumatology</p><p>Moscow</p></bio><email xlink:type="simple">m_nn2001@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5263-6743</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сновская</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Snovskaya</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сновская Марина Андреевна, к. м. н., в. н. с. лаборатории экспериментальной иммунологии и вирусологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Snovskaya Marina A., PhD Med, Leading Research Associate of laboratories of experimental immunology and virology</p><p>Moscow</p></bio><email xlink:type="simple">snows@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАУ «НМИЦ здоровья детей» МЗ РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Children’s Health</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАУ «НМИЦ здоровья детей» МЗ РФ; ФГБОУ ВО «МГУ им. М. В. Ломоносова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Children’s Health; M.V. Lomonosov Moscow State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАУ «НМИЦ здоровья детей» МЗ РФ; ФГБУ ДПО «ЦГМА»; ФГАОУ ВО «Первый МГМУ им. И. М. Сеченова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Children’s Health; Central State Medical Academy of the Administrative Directorate of the President of the Russian Federation; Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>14</day><month>06</month><year>2023</year></pub-date><volume>0</volume><issue>8</issue><issue-title>«Диетология и нутрициология» (1)</issue-title><fpage>82</fpage><lpage>85</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Галимова А.А., Макарова С.Г., Мурашкин Н.Н., Сновская М.А., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Галимова А.А., Макарова С.Г., Мурашкин Н.Н., Сновская М.А.</copyright-holder><copyright-holder xml:lang="en">Galimova A.A., Makarova S.G., Murashkin N.N., Snovskaya M.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/3125">https://www.med-alphabet.com/jour/article/view/3125</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. Врожденный буллезный эпидермолиз (ВБЭ) относится к группе тяжело протекающих редких наследственных механобуллезных заболеваний. Зачастую кожный патологический процесс тяжело поддается лечению, что приводит к снижению качества жизни таких пациентов. Не исключается механизм развития транскутанной сенсибилизации у данной категории больных. Данный вопрос остается весьма актуальным направлением для изучения, учитывая характерную нутритивную недостаточность и возникающие сложности при формировании рациона.</p></sec><sec><title>Цель</title><p>Цель: оценить частоту встречаемости и особенности профиля пищевой сенсибилизации у детей с ВБЭ.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследуемую группу включены 164 ребенка с ВБЭ (45 с простой формой и 119 с дистрофической). Всем пациентам проводились оценка аллергологического анамнеза, определение уровня общего IgE и специфических IgE сыворотки крови к наиболее значимым пищевым аллергенам (UniCAP System, Thermo Fisher Scientific). Результаты: пищевая сенсибилизация была выявлена у 34,1 % детей с ВБЭ (в 38,7 % случаев при дистрофической и в 24,4 % –  при простой форме ВБЭ). Среди проявлений пищевой аллергии в обеих группах чаще встречались кожные симптомы. В качестве этиологического фактора наиболее часто выступали продукты, содержащие белок коровьего молока, яйца, злаки. В группе детей с коморбидной пищевой аллергией и ВБЭ наиболее часто встречались высокие и крайне высокие уровни общего Ig E.</p></sec><sec><title>Заключение</title><p>Заключение. Показана высокая частота пищевой сенсибилизации у пациентов с ВБЭ, что важно не только с научной, но и с практической точки зрения. Учитывая характерный для данного заболевания дефицит нутриентов, сложности нутритивной поддержки, наличие коморбидной пищевой аллергии должно приниматься во внимание при рекомендациях по питанию и подборе лечебных продуктов этой категории больных.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Inherited epidermolysis bullosa belongs to the group of severe rare hereditary mechanobullous diseases. Often, the skin pathological process is difficult to treat, which leads to a decrease in the quality of life of such patients. The mechanism of development of transcutaneous sensitization in this category of patients is not excluded. This issue remains a very relevant area for study, given the characteristic nutritional deficiency and the difficulties that arise in the formation of the diet.</p></sec><sec><title>The aim</title><p>The aim: to assess the frequency of occurrence and characteristics of food sensitization in children with epidermolysis bullosa.</p></sec><sec><title>Materials and methods</title><p>Materials and methods: the group included 164 children with epidermolysis bullosa (45 with rapid detection and 119 with dystrophic). For all patients, an assessment of the risk of an allergic history, determination of the total level of IgE and specific IgE of blood serum to the most significant food allergens (UniCAP system, Thermo Fisher Scientific). Results: food sensitization was detected in 34.1 % of children with epidermolysis bullosa (in 38.7 % of cases with dystrophic and in 24.4 % with a simple form of epidermolysis bullosa). Among the manifestations of food allergy in both groups, skin symptoms were more common. The most common etiological factors were products containing cow’s milk protein, eggs, and cereals. In the group of children with comorbid food allergies and epidermolysis bullosa, high and extremely high levels of total IgE were most common.</p></sec><sec><title>Conclusion</title><p>Conclusion: a high frequency of food sensitization in patients with epidermolysis bullosa, was shown, which is important not only from a scientific, but also from a practical point of view. Given the nutritional deficiency characteristic of this disease, the complexity of nutritional support, the presence of comorbid food allergies should be taken into account when recommending nutrition and selecting therapeutic products for this category of patients.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>врожденный буллезный эпидермолиз</kwd><kwd>пищевая сенсибилизация</kwd><kwd>транскутанная сенсибилизация</kwd><kwd>аллергия</kwd><kwd>дети</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Inherited epidermolysis bullosa</kwd><kwd>food sensitization</kwd><kwd>transcutaneous sensitization</kwd><kwd>allergy</kwd><kwd>children</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Fine J. D. Epidemiology of Inherited Epidermolysis Bullosa Based on Incidence and Prevalence Estimates From the National Epidermolysis Bullosa Registry. JAMA Dermatol. 2016 Nov 1;152(11):1231–1238. DOI: 10.1001/jamadermatol.2016.2473. PMID: 27463098</mixed-citation><mixed-citation xml:lang="en">Fine J. D. Epidemiology of Inherited Epidermolysis Bullosa Based on Incidence and Prevalence Estimates From the National Epidermolysis Bullosa Registry. JAMA Dermatol. 2016 Nov 1;152(11):1231–1238. DOI: 10.1001/jamadermatol.2016.2473. PMID: 27463098</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Mariath L. M., Santin J. T., Schuler-Faccini L., Kiszewski A. E. Inherited epidermolysis bullosa: update on the clinical and genetic aspects. An Bras Dermatol. 2020. Vol. 95. N 5. Р. 551–569. DOI: 10.1016/j.abd.2020.05.001</mixed-citation><mixed-citation xml:lang="en">Mariath L. M., Santin J. T., Schuler-Faccini L., Kiszewski A. E. Inherited epidermolysis bullosa: update on the clinical and genetic aspects. An Bras Dermatol. 2020. Vol. 95. N 5. Р. 551–569. DOI: 10.1016/j.abd.2020.05.001</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Has C., Fischer J. Inherited epidermolysis bullosa: New diagnostics and new clinical phenotypes // Exp Dermatol. 2019. Vol. 28. N 10. Р. 1146–1152. DOI: 10.1111/exd.13668</mixed-citation><mixed-citation xml:lang="en">Has C., Fischer J. Inherited epidermolysis bullosa: New diagnostics and new clinical phenotypes // Exp Dermatol. 2019. Vol. 28. N 10. Р. 1146–1152. DOI: 10.1111/exd.13668</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Has C., Bauer J. W., Bodemer C. et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br. J. Dermatol. 2020. Vol. 183. N 4. Р. 614–627. DOI: 10.1111/bjd.18921</mixed-citation><mixed-citation xml:lang="en">Has C., Bauer J. W., Bodemer C. et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br. J. Dermatol. 2020. Vol. 183. N 4. Р. 614–627. DOI: 10.1111/bjd.18921</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kabashima K., Honda, T., Ginhoux F. et al. The immunological anatomy of the skin. Nat Rev Immunol 19, 19–30 (2019). https://doi.org/10.1038/s41577–018–0084–5</mixed-citation><mixed-citation xml:lang="en">Kabashima K., Honda, T., Ginhoux F. et al. The immunological anatomy of the skin. Nat Rev Immunol 19, 19–30 (2019). https://doi.org/10.1038/s41577–018–0084–5</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chiaverini C., Marty M., Dridi S. M., Campana S. C., Canceill T., Bailleul-Forestier I., Verhaeghe V., Declerck D., Hubiche T., Kémoun P., Mazereeuw-Hautier J., Joseph C. Oral status in patients with inherited epidermolysis bullosa: A multicentric observational study. J. Am. Acad. Dermatol. 2022 Oct;87(4):872–874. DOI: 10.1016/j.jaad.2021.11.039. Epub 2021 Nov 25. PMID: 34838879.</mixed-citation><mixed-citation xml:lang="en">Chiaverini C., Marty M., Dridi S. M., Campana S. C., Canceill T., Bailleul-Forestier I., Verhaeghe V., Declerck D., Hubiche T., Kémoun P., Mazereeuw-Hautier J., Joseph C. Oral status in patients with inherited epidermolysis bullosa: A multicentric observational study. J. Am. Acad. Dermatol. 2022 Oct;87(4):872–874. DOI: 10.1016/j.jaad.2021.11.039. Epub 2021 Nov 25. PMID: 34838879.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Буллезный эпидермолиз: руководство для врачей / под ред. Н. Н. Мурашкина, Л. С. Намазовой-Барановой. М.: ПедиатрЪ, 2019. 443 с.</mixed-citation><mixed-citation xml:lang="en">Epidermolysis bullosa: A guide for doctors. Ed. by N. N. Murashkin, L. S. Namazova-Baranova. Moscow: Pediatr”; 2019. 443 р</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Boeira V. L., Souza E. S., Rocha Bde O., Oliveira P. D., Oliveira Mde F., Rêgo V. R., Follador I. Inherited epidermolysis bullosa: clinical and therapeutic aspects. An Bras Dermatol. 2013 Mar-Apr;88(2):185–98. DOI: 10.1590/S0365–05962013000200001. PMID: 23739692; PMCID: PMC 3750879.</mixed-citation><mixed-citation xml:lang="en">Boeira V. L., Souza E. S., Rocha Bde O., Oliveira P. D., Oliveira Mde F., Rêgo V. R., Follador I. Inherited epidermolysis bullosa: clinical and therapeutic aspects. An Bras Dermatol. 2013 Mar-Apr;88(2):185–98. DOI: 10.1590/S0365–05962013000200001. PMID: 23739692; PMCID: PMC 3750879.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bloomfield S. F., Rook G. A., Scott E. A., Shanahan F., Stanwell-Smith R., Turner P. Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene. Perspect Public. Health. 2016;136:213–224.</mixed-citation><mixed-citation xml:lang="en">Bloomfield S. F., Rook G. A., Scott E. A., Shanahan F., Stanwell-Smith R., Turner P. Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene. Perspect Public. Health. 2016;136:213–224.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Izadi N., Luu M., Ong P. Y., Tam J. S. The role of skin barrier in the pathogenesis of food allergy. Children (Basel). 2015;2(3):382–402. DOI: 10.3390/children2030382</mixed-citation><mixed-citation xml:lang="en">Izadi N., Luu M., Ong P. Y., Tam J. S. The role of skin barrier in the pathogenesis of food allergy. Children (Basel). 2015;2(3):382–402. DOI: 10.3390/children2030382</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cabanillas B., Brehler A. C., Novak N. Atopic dermatitis phenotypes and the need for Personalized medicine. Curr. Opin. doi: 10.1097/ACI.0000000000000376</mixed-citation><mixed-citation xml:lang="en">Cabanillas B., Brehler A. C., Novak N. Atopic dermatitis phenotypes and the need for Personalized medicine. Curr. Opin. doi: 10.1097/ACI.0000000000000376</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
